ACM
ANGO icon

Altium Capital Management’s AngioDynamics ANGO Stock Holding History

Altium Capital Management’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-195,000
Closed -$3.99M – 99
2022
Q3 		$3.99M Buy
195,000
+155,360
+392% +$3.41M 1.46% 23
2022
Q2 		$767K Buy
+39,640
New +$812K 0.31% 85

Other funds holding ANGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Altium Capital Management's ANGO Position: Q4 2022 in Review

Altium Capital Management sold out of AngioDynamics (ANGO) in Q4 2022, closing a stake of 195,000 shares — an estimated $3.99M sold.

Altium Capital Management first reported a position in ANGO in Q2 2022 and held it in 2 quarters. The position peaked at $3.99M in Q3 2022. 149 funds tracked by Wall St. Rank hold ANGO as of Q4 2022.

  • Altium Capital Management reported no remaining AngioDynamics position as of Q4 2022 after selling out during the quarter.
  • Altium Capital Management sold 195,000 AngioDynamics shares in Q4 2022, an estimated $3.99M.
  • Altium Capital Management first reported a position in AngioDynamics in Q2 2022 and held it in 2 quarters.
  • Altium Capital Management's AngioDynamics position peaked at $3.99M in Q3 2022.
  • 149 funds tracked by Wall St. Rank held AngioDynamics as of Q4 2022.

Based on Altium Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.